|
Variables
|
N = 78
|
|---|
|
On admission
|
|
Age, years (SD)
|
62 ± 11
|
|
Male sex, n (%)
|
65 (83)
|
|
Body mass index, kg/m2 (IQR)
|
27 (25-30)
|
|
Ischemia time, minutes (IQR)
|
173 (140-239)
|
|
Current smoker, n (%)
|
24 (31)
|
|
Hypertension, n (%)
|
18 (23)
|
|
Dyslipidemia, n (%)
|
6 (8)
|
|
Previous angina, n (%)
|
9 (12)
|
|
Previous known diabetes mellitus, n (%)
|
2 (3)
|
|
Treatment on admission
|
|
Aspirin, n (%)
|
5 (6)
|
|
Beta-blocker, n (%)
|
6 (8)
|
|
ACE/ARB, n (%)
|
7 (9)
|
|
Statin
|
6 (8)
|
|
Treatment at discharge
|
|
Aspirin, n (%)
|
77 (99)
|
|
Clopidogrel, n (%)
|
78 (100)
|
|
Beta-blocker, n (%)
|
77 (99)
|
|
ACE/ARB, n (%)
|
44 (56)
|
|
Statin, n (%)
|
76 (97)
|
- Data are presented as number of patients and percentage in brackets for dichotomous variables or median and interquartile range. ACE angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, IQR inter-quartile range
